n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Thrombosis in 4 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Aspirin was injected at 100 mg/kg, 1 mg/kg and at several different aspirin dilutions along with cyclooxygenase (COX) 1 (SC-560), COX 2 (NS-398) or both selective inhibitors simultaneously using a laser-induced thrombosis model." | 3.76 | Paradoxical thrombotic effects of aspirin: experimental study on 1000 animals. ( Aguejouf, O; Desplat, V; Doutremepuich, C; Eizayaga, FX, 2010) |
| "We studied the effects of ultra-low-dose aspirin (ULDA) as well as those of sc-560 and ns-398, specific COX-1 and COX-2 inhibitors, on induced hemorrhagic time and in a model of laser-induced thrombosis in rats." | 3.74 | Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition? ( Aguejouf, O; Desplat, V; Doutremepuich, C; Eizayaga, FX, 2007) |
| " Platelet aggregation induced by ADP and dosing of prostanoid products 6-keto-PGF1alpha, TXB2, PGE2 and LTB4 were also performed." | 1.34 | Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension. ( Aguejouf, O; Belon, P; Desplat, V; Doutremepuich, C; Eizayaga, FX, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Z | 1 |
| Liu, P | 1 |
| Hu, M | 1 |
| Lu, S | 1 |
| Lyu, Z | 1 |
| Kou, Y | 1 |
| Sun, Y | 1 |
| Zhao, X | 1 |
| Liu, F | 1 |
| Tian, J | 1 |
| Doutremepuich, C | 3 |
| Aguejouf, O | 3 |
| Desplat, V | 3 |
| Eizayaga, FX | 3 |
| Belon, P | 1 |
4 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Thrombosis
| Article | Year |
|---|---|
Naoxintong restores ischemia injury and inhibits thrombosis via COX2-VEGF/ NFκB signaling.
Topics: Animals; Apoptosis; Cell Line; Cell Survival; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease M | 2021 |
Paradoxical thrombotic effects of aspirin: experimental study on 1000 animals.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Dose-Response | 2010 |
Modifications produced by selective inhibitors of cyclooxygenase and ultra low dose aspirin on platelet activity in portal hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Platelets; Cyclooxygenase Inhibitors; Dinopros | 2007 |
Reverse effect of aspirin: is the prothrombotic effect after aspirin discontinuation mediated by cyclooxygenase 2 inhibition?
Topics: Animals; Aspirin; Bleeding Time; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cy | 2007 |